You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Letters Quality Improvement Strategies for Type 2 Diabetes—Reply
Kaveh G. Shojania; Sumant R. Ranji; Kathryn M. McDonald; Jeremy M. Grimshaw; Robert J. Rushakoff; Douglas K. Owens
JAMA 2006; 296: 2681.
[Extract][Full text][PDF]
Original Contributions Relationship Between Medicare’s Hospital Compare Performance Measures and Mortality Rates
Letters Risk of Serious Infections and Malignancies With Anti-TNF Antibody Therapy in Rheumatoid Arthritis
Karen H. Costenbader; Roberta Glass; Jing Cui; Nancy Shadick
JAMA 2006; 296: 2201.
[Extract][Full text][PDF]
Letters Risk of Serious Infections and Malignancies With Anti-TNF Antibody Therapy in Rheumatoid Arthritis
Peter E. Callegari; Thomas F. Schaible; Jerome A. Boscia
JAMA 2006; 296: 2202.
[Extract][Full text][PDF]
Letters Risk of Serious Infections and Malignancies With Anti-TNF Antibody Therapy in Rheumatoid Arthritis—Reply
Tim Bongartz; Eric L. Matteson; Victor M. Montori; Alex J. Sutton; Michael Sweeting; Iain Buchan
JAMA 2006; 296: 2203-a-2204-a.
[Extract][Full text][PDF]
